Zealand Pharma A/S was founded in and is a biotechnology company focused on the discovery, design and development of innovative peptide based medicines. We intend to be a leader in specialty medicines focusing on metabolic and gastrointestinal diseases and other specialty disease areas with significant unmet medical needs. Zealand has a portfolio of medicines and product candidates under license collaborations with Sanofi and Boehringer Ingelheim.
Quote | Zealand Pharma A/S Ord (OTCMKTS:ZLDPF)
Last: | $130.54 |
---|---|
Change Percent: | 2.67% |
Open: | $128.34 |
Close: | $127.15 |
High: | $130.79 |
Low: | $128.34 |
Volume: | 1,248 |
Last Trade Date Time: | 07/03/2024 03:00:00 am |
News | Zealand Pharma A/S Ord (OTCMKTS:ZLDPF)
2024-07-02 11:20:47 ET Summary This article will outline nine steps I use to identify the most promising pharmaceutical companies and avoid investment pitfalls. In addition, each of the nine steps will provide examples of various factors and how they influence the assessment of th...
Company announcement – No. 35 / 2024 Zealand Pharma announces completion of an upsized equity offering of 8.35 million new ordinary shares raising gross proceeds of USD 1 billion / DKK 7 billion NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN OR INTO THE U...
Message Board Posts | Zealand Pharma A/S Ord (OTCMKTS:ZLDPF)
Subject | By | Source | When |
---|---|---|---|
PR Release - FDA approval - Type II Diabetes. | Trading2retire | investorshub | 11/22/2016 2:29:27 AM |
$ZLDPF recent news/filings | stocktrademan | investorshub | 09/16/2015 3:49:35 PM |
$ZLDPF recent news/filings | stocktrademan | investorshub | 06/11/2015 7:14:17 PM |
News, Short Squeeze, Breakout and More Instantly...
Zealand Pharma A/S Ord Company Name:
ZLDPF Stock Symbol:
OTCMKTS Market:
Zealand Pharma A/S Ord Website:
Company announcement – No. 35 / 2024 Zealand Pharma announces completion of an upsized equity offering of 8.35 million new ordinary shares raising gross proceeds of USD 1 billion / DKK 7 billion NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN OR INTO THE U...
Company announcement – No. 34 / 2024 Zealand Pharma announces upsizing of previously announced equity offering from approximately USD 900 million / DKK 6.257 billion to USD 1 billion / DKK 7 billion NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN OR INTO T...
Company announcement – No. 33 / 2024 Zealand Pharma launches equity offering of new shares raising gross proceeds of approximately USD 900 million / DKK 6.257 billion NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN OR INTO THE UNITED STATES, AUSTRALIA, CAN...